BioSpace News Archive

UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced the grants of inducement restricted stock units (“RSUs”) to nine new employees in connection with their employment with UroGen. These new team members will support the ongoing commercial launch of Jelmyto® (mitomycin) for pyelocalyceal

Navitus Health Solutions, a full pass-through pharmacy benefit manager (PBM), announced today that it won platinum awards for Best Annual Drug Trend Report and Best Integrated Marketing Campaign from the 21 st Annual eHealthcare Leadership Awards . Announced at the healthcare internet conference’s virtual HCIC@Home conference, the eHealthcare Leadership Awards honor the best websites and digital communications from a broa

IDBS, a software informatics solution provider for biotech and pharma, today announced the launch of Polar™, establishing a new product category, BioPharma Lifecycle Management (BPLM), aimed at streamlining drug development and manufacturing in biopharma research.

IVERIC bio, Inc. (NASDAQ: ISEE) today reported that on December 3, 2020, the Company granted a newly hired employee equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan. The inducement grants were approved by the Company’s compensation committee pursuant to a delegation by the Company’s board of directors and were made as a material inducement to the employee’s acceptance of employment with the Comp

Vapotherm, Inc. (NYSE:VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® systems, has been awarded the prestigious American Association for Respiratory Care Zenith Award.

Momentus Inc. (“Momentus”), a commercial space company offering in-space infrastructure services, today announced it will participate at the Truist Securities Industrials and Services Summit on Tuesday, December 8, 2020.

Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that a scientific update on its non-thermal NPS mechanism will be featured at the upcoming Controversies and Conversations in Lasers & Cosmetic Surgery Symposium.

Magenta Therapeutics (NASDAQ: MGTA) and bluebird bio, Inc. (NASDAQ: BLUE) today announced an exclusive clinical trial collaboration to evaluate the utility of MGTA-145, in combination with plerixafor, for mobilization and collection of stem cells in adults and adolescents with sickle cell disease (SCD).

With a focus on advancing knowledge through research and discovery, The University of Texas at San Antonio (UTSA) closed out fiscal year 2020 with its highest total research expenditure numbers in its 51-year history. In FY 2020, UTSA’s total research expenditures increased to $134 million. This is a significant milestone for UTSA as it propels toward National Research University Fund (NRUF) eligibility and recognition as a C

Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced it will participate in AES2020 – the all-new virtual event for epilepsy professionals in academia, clinical practice, industry and advocacy, on Dec. 4–8, 2020.